First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody–Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer
2017 ◽
2017 ◽
Vol 35
(4)
◽
pp. 451-462
◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. 11010-11010
◽
2019 ◽
Vol 25
(16)
◽
pp. 4888-4897
◽
2012 ◽
Vol 48
◽
pp. 191-192
◽